Omnipod 5 DEXG7G6 pods (GEN 5) 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FXSR7
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,295
Award facts
- Contract value 100% obligated
- $24,295.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $24,295.15 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for OmniPod 5 Dexcom G7 Generation 5 insulin infusion pods. The delivery order, which is non-set-aside and competitively awarded, has an ultimate completion date of January 7, 2026, with performance to take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.9 million through December 2026, which serves as the company's primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that supplies a comprehensive range of medical products to federal agencies, particularly the Department of Defense and veterans' healthcare systems. As a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), the company demonstrates significant capability in fulfilling competitive federal medical procurement requirements across multiple therapeutic domains. The DLA's utilization of firm fixed-price delivery orders through this established IDC reflects the agency's confidence in AmerisourceBergen's ability to provide specialized medical devices and supplies efficiently to military treatment facilities and other federal healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FXSR7?
SPE2DR26FXSR7 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26FXSR7 worth?
The government has obligated $24,295 on SPE2DR26FXSR7.
Is contract SPE2DR26FXSR7 an order under another contract?
Yes. SPE2DR26FXSR7 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXSR7 competed?
The extent of competition for SPE2DR26FXSR7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award